Statins and ARBs on Rheumatoid Activity

Phase 3RecruitingNCT03770702

Sherief Abd-Elsalam45 enrolled

Overview

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

The study aims at ivestigating and comparing the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Rheumatoid Arthritis

Interventions

Angiotensin receptor blockersDRUG

Candesartan

StatinsDRUG

Atorvastatin

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Rheumatoid arthritis. Exclusion Criteria: * Pregnant or lactating * Hepatic or renal impairment.

Locations (1)

Sherief Abd-Elsalam

Tanta, Egypt

RECRUITING

Outcomes

Primary Outcomes

Change in disease activity score

DAS28-ESR

Time frame: 6 months

Central Contacts

Sherief Abd-Elsalam, Ph D

CONTACT

00201147773440 sheriefabdelsalam@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.